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Methods
Samples were prepared using the Platinum 
Taq DNA Polymerase High Fidelity system 
from Thermo Fisher. Two agarose gels were 
run to isolate the target DNA sequence via 
weight. A 0.8% for the heavier PCDH-19 
and NCAD and a 1.5% for the signal peptide 
of PCDH-19 and GFP which were then run 
through PCR again together with primers 
in order to produce a recombinant gene. 
Each gene (PCDH-19, NCAD, RYK and the 
recombinant) was then put through a 
restriction digest using Nhe 1 for all and 
not 1 for the recombinant gene and a CMV 
strep-N1 vector, all other sequences were 
cut with BamH1.  Target sequences were 
again isolated and purified using gel 
electrophoresis and Gel/PCR Cleanup kit. 
Ligation was then performed using T4 DNA 
ligase to add PCHD-19 and the 
recombinant gene into a CMV GFP-N1 
plasmid and the NCAD and RYK genes into 
a CMV Strep-N1 plasmid vector. Successful 
ligations were found via gel electrophoresis 
and used to transform DH5𝞪𝞪 Competent 
cells. The plasmid contained a kanamycin 
resistance gene which was used to identify 
successfully transformed cells. The 




Abstract Classical Sequencing Results
Future Directions
Throughout this semester, work has 
been done to generate copies of the 
human genes for protocadherin-19
(PCDH-19), neural cadherin (NCAD), 
receptor-like tyrosine kinase (RYK), 
and a recombinant protein of Green 
Fluorescent Protein (GFP) with a 
Protocadherin-19 signal peptide that 
would create a form of GFP secreted 
from the cell. These cloned vectors 
would then be able to be used to study 
whether disruptions of interactions 
between these proteins lead to a female-
specific form of epilepsy. These 
plasmids containing cloned human 
genes will allow for neurodevelopmental 
protein interactions to be tested in a 
mammalian cell culture system in future 
experiments.
Once fully generated and isolated via miniprep, plasmids were then prepared for classical 
sequencing. Sequencing was performed at Ohio State university and data processing was performed 
using BioEdit software and NCBI BLAST to evaluate what DNA sequences were present in the 
samples.
• Successful ligation of PCDH-19 with a 
100% match to the database 
• Successful ligation of NCAD with a 
98.5% match to the data base (5 
nucleotide mismatches)
• Successful recombination of the signal 
peptide of PCDH-19 with GFP as well as 
successful ligation of the new sequence. 
• The RYK sequencing returned an 
unsuccessful experiment result and will 
need to be repeated.
These cloned genes contained in 
plasmid vectors will be used in future 
research to investigate the interactions 
between the neurodevelopmental 
proteins. They can be used to transfect 
mammalian cells for experimentation, 
or they can be used to transform 
bacteria in order to produce many 
copies of the proteins. This project’s 
goal was achieved in generating a stock 
of human gene-containing plasmids for 
use in future experimentation.
Figure 1. Agarose gel 
of the plasmid 
vectors 
demonstrating a 
successful ligation of 
PCHD-19 (lane 2), 
NCAD (lane 4), and 
RYK (lane 6). DNA 
ladder in lane 1 (1 kb 
plus ladder)
Figure 3. Example of DNA sequence in BioEdit
Figure 2. Agarose gel 
of the plasmid 
vectors 
demonstrating a 
successful ligation of 
the recombinant 
protein (PCDH-19 
signal peptide ~70 
bp and GFP 
~700bp) in lane 2. 
DNA ladder in lane 2 
(1 kb plus ladder).
